(Q37914638)

25 August 2017

1 reference

title

Management of patients with hepatocellular carcinoma and extrahepatic metastasis (English)

1 reference

25 August 2017

main subject

hepatocellular carcinoma

1 reference

Hyo-Suk Lee

1

1 reference

25 August 2017

publication date

9 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

29

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

333-338

1 reference

Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors

25 August 2017

cites work

1 reference

Clinical features of hepatocellular carcinoma with extrahepatic metastases.

21 January 2018

1 reference

Extrahepatic Metastases of Hepatocellular Carcinoma

21 January 2018

1 reference

Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma

21 January 2018

1 reference

Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis

21 January 2018

1 reference

Extrahepatic spread from hepatocellular carcinoma: who are candidates for aggressive anti-cancer treatment?

21 January 2018

1 reference

Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum

21 January 2018

1 reference

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

21 January 2018

1 reference

Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy

21 January 2018

1 reference

Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5-fluorouracil combined with interferon-alpha in a hemodialysis patient

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response.

21 January 2018

1 reference

Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease

21 January 2018

1 reference

Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinoma

21 January 2018

1 reference

Radiotherapy for painful bone metastases from hepatocellular carcinoma.

21 January 2018

1 reference

Intracranial metastasis of hepatocellular carcinoma: review of 45 cases

21 January 2018

1 reference

Clinical and radiological pictures of hepatocellular carcinoma with intracranial metastasis.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000327572

1 reference

25 August 2017

1 reference